$JNJ

Quitting at 59 and Bridging Eight Years to Social Security at 67? Here Is the $530,000 Income Portfolio I Would Build

HDV: This May Not Be The ETF You Want, But It Could Be The One You Need Right Now

Johnson & Johnson: A Dividend King, But Priced Appropriately, Big Conference Slate

CDL’s $2.29 annual dividend beats Treasury yields despite rising interest rates

Vanguard’s VIG Quietly Returned 247% While Investors Chased Higher Yields

J&J & Pfizer Face Patent Risks: Which Stock Looks Better Positioned?

Three Bond ETFs and Three High-Yield Equity ETFs: How $740,000 Pays $44,000 a Year Without Sector Drama

IBRX Says ANKTIVA Delivers Up To $314K Cost Advantage Over J&J's TAR-200 — Everything To Know About ImmunityBio’s Findings

The 6.4 Percent Yield Portfolio That Lets a 70-Year-Old Sleep Through Every Market Selloff Since 2020

The Dividend Stocks That Can Replace a $65,000 Income and What They’ll Cost You